Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 7Carcinoma, Medullary 5Thyroid Neoplasms 4Thyroid Cancer, Papillary 3Sarcoma 3Lung Neoplasms 3Central Nervous System Neoplasms 3Wilms Tumor 2Thyroid Diseases 2Thoracic Neoplasms 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Respiratory Tract Neoplasms 2Respiratory Tract Diseases 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Neoplasms by Site 2Neoplasms 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Lung Diseases 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Head and Neck Neoplasms 2Glioma 2Ependymoma 2Endocrine System Diseases 2Endocrine Gland Neoplasms 2

Interventions

trametinib 3pembrolizumab 2lenvatinib 2dabrafenib 2Paclitaxel 2Nivolumab 2selpercatinib 1fludarabine 1cobimetinib 1atezolizumab 1aldesleukin 1Vemurafenib 1Taxes 1Radiotherapy, Intensity-Modulated 1Ipilimumab 1Immunoglobulin G 1Disulfides 1Cyclophosphamide 1CTLA-4 Antigen 1Bevacizumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Thyroid Carcinoma, Anaplastic × selpercatinib × Clear all
NCT04759911 2026-05-20

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
30 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡